UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 342

Sortiert nach

Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer

Annals of oncology, 2014-02, Vol.25 (2), p.352-357

2014

Link zum Volltext

Verfügbarkeit prüfen

Proteomic profile in familial breast cancer patients

Clinical biochemistry, 2013-02, Vol.46 (3), p.259-265

2013

Link zum Volltext

Verfügbarkeit prüfen

RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features

Clinical cancer research, 1998-01, Vol.4 (1), p.223-228

1998

Link zum Volltext

Verfügbarkeit prüfen

Characterization of a serum protein pattern from NSCLC patients treated with Gefitinib

Clinical biochemistry, 2011-07, Vol.44 (10), p.936-940

2011

Link zum Volltext

Verfügbarkeit prüfen

SH2B1β adaptor is a key enhancer of RET tyrosine kinase signaling

Oncogene, 2007-10, Vol.26 (45), p.6546-6559

2007

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A

Molecular and Cellular Biology, 1993-01, Vol.13 (1), p.358-366

1993

Link zum Volltext

Verfügbarkeit prüfen

Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: Identification of new signaling elements

Molecular carcinogenesis, 2009-03, Vol.48 (3), p.220-231

2009

Link zum Volltext

Verfügbarkeit prüfen

Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma

The journal of clinical endocrinology and metabolism, 1996-05, Vol.81 (5), p.2006-2010

1996

Link zum Volltext

Verfügbarkeit prüfen

Thyroid iatrogenic sequelae after the treatment of pediatric cancer

The quarterly journal of nuclear medicine and molecular imaging, 2009-10, Vol.53 (5), p.526

2009

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas

Oncogene, 1992-12, Vol.7 (12), p.2549-2553

1992

Link zum Volltext

Verfügbarkeit prüfen

Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas

Cancer research (Chicago, Ill.), 1994-06, Vol.54 (11), p.2979-2985

1994

Link zum Volltext

Verfügbarkeit prüfen

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer

Oncogene, 2004-09, Vol.23 (44), p.7436-7440

2004

Link zum Volltext

Verfügbarkeit prüfen

RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism

Cellular signalling, 2006-12, Vol.18 (12), p.2272-2282

2006

Link zum Volltext

Verfügbarkeit prüfen

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype

The Journal of clinical investigation, 1992-05, Vol.89 (5), p.1517-1522

1992

Link zum Volltext

Verfügbarkeit prüfen

TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas

Oncogene, 1992-02, Vol.7 (2), p.237-242

1992

Link zum Volltext

Verfügbarkeit prüfen

Identification of MET and SRC Activation in Melanoma Cell Lines Showing Primary Resistance to PLX4032

Neoplasia (New York, N.Y.), 2011-12, Vol.13 (12), p.1132-IN17

2011

Link zum Volltext

Verfügbarkeit prüfen

Characterization of an Inversion on the Long Arm of Chromosome 10 Juxtaposing D10S170 and RET and Creating the Oncogenic Sequence RET/PTC

Proceedings of the National Academy of Sciences - PNAS, 1992-03, Vol.89 (5), p.1616-1620

1992

Link zum Volltext

Verfügbarkeit prüfen

High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma

Oncogene, 1989-12, Vol.4 (12), p.1457-1462

1989

Link zum Volltext

Verfügbarkeit prüfen

602 Identification of HSP105 as a novel non-Hodgkin lymphoma restricted antigen

European journal of cancer supplements, 2010, Vol.8 (7), p.189-189

2010

Link zum Volltext

Verfügbarkeit prüfen

56 A novel interplay between Ret oncoprotein and Fap-1 controls CD95-mediated apoptosis in medullary thyroid cancer

European journal of cancer supplements, 2010, Vol.8 (7), p.26-27

2010

Link zum Volltext

Verfügbarkeit prüfen

Expression of Angiogenesis Stimulators and Inhibitors in Human Thyroid Tumors and Correlation with Clinical Pathological Features

The American journal of pathology, 1999-12, Vol.155 (6), p.1967-1976

1999

Link zum Volltext

Verfügbarkeit prüfen

Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas

Recent results in cancer research, 1998, Vol.154, p.237

1998

Link zum Volltext

Verfügbarkeit prüfen

trk and ret proto‐oncogene expression in human neuroblastoma specimens: High frequency of trk expression in non‐advanced stages

International journal of cancer, 1993-06, Vol.54 (4), p.540-545

1993

Link zum Volltext

Verfügbarkeit prüfen

Proteomic Identification of LASP-1 Down-regulation After RNAi Urokinase Silencing in Human Hepatocellular Carcinoma Cells

Neoplasia (New York, N.Y.), 2009-02, Vol.11 (2), p.207,IN13-219,IN13

2009

Link zum Volltext

Verfügbarkeit prüfen

A perioperative surgeon-controlled open-lung approach versus conventional protective ventilation with low positive end-expiratory pressure in cardiac surgery with cardiopulmonary bypass (PROVECS): study protocol for a randomized controlled trial

Trials, 2018-11, Vol.19 (1), p.624-624, Article 624

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 342

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(322)
Mit Volltextzugriff
(308)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer

Proteomic profile in familial breast cancer patients

RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features

Characterization of a serum protein pattern from NSCLC patients treated with Gefitinib

SH2B1β adaptor is a key enhancer of RET tyrosine kinase signaling

Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A

Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: Identification of new signaling elements

Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma

Thyroid iatrogenic sequelae after the treatment of pediatric cancer

Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas

Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer

RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype

TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas

Identification of MET and SRC Activation in Melanoma Cell Lines Showing Primary Resistance to PLX4032

Characterization of an Inversion on the Long Arm of Chromosome 10 Juxtaposing D10S170 and RET and Creating the Oncogenic Sequence RET/PTC

High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma

602 Identification of HSP105 as a novel non-Hodgkin lymphoma restricted antigen

56 A novel interplay between Ret oncoprotein and Fap-1 controls CD95-mediated apoptosis in medullary thyroid cancer

Expression of Angiogenesis Stimulators and Inhibitors in Human Thyroid Tumors and Correlation with Clinical Pathological Features

Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas

trk and ret proto‐oncogene expression in human neuroblastoma specimens: High frequency of trk expression in non‐advanced stages

Proteomic Identification of LASP-1 Down-regulation After RNAi Urokinase Silencing in Human Hepatocellular Carcinoma Cells

A perioperative surgeon-controlled open-lung approach versus conventional protective ventilation with low positive end-expiratory pressure in cardiac surgery with cardiopulmonary bypass (PROVECS): study protocol for a randomized controlled trial

Suchergebnisse filtern